Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03290378 · ClinicalTrials.gov registry record · Phase 3

Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy

A Phase 3 study of Pain Management, sponsored by Avenue Therapeutics.

Completed
Registry status
Phase 3
Development phase
409
Enrollment target
5
Study locations

NCT03290378 is a Phase 3 study of Pain Management that has completed, run by Avenue Therapeutics. The registered enrollment target is 409 participants, above the 142-participant average among 31 other Pain Management trials with a reported enrollment target (188% higher). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03290378, a Phase 3 study of Pain Management, has completed, sponsored by Avenue Therapeutics.

COMPLETED
Registry status
Phase 3
Development phase
409 participants
Enrollment target
5
Study locations

Study Summary

The study evaluates the effectiveness and safety of IV tramadol compared to placebo managing postoperative pain following a bunionectomy

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Tramadol

Study Locations (5)

California

  • Trovare Clinical Research - Bakersfield
  • Lotus Clinical Research - Pasadena

Texas

  • H.D. Research Corporation - Houston
  • Endeavor Clinical Trials, PA - San Antonio

Maryland

  • Cheseapeake Research Group, LLC - Pasadena

Trial Details

FieldValue
Enrollment Target 409 participants
Start Date 2017-09-19
Est. Completion 2018-04-23
Phase Phase 3

Sponsor

Avenue Therapeutics

3 total trials

What the Registry Record Tells You About NCT03290378

The ClinicalTrials.gov registry entry for NCT03290378 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 142-participant average among 31 other Pain Management trials with a reported enrollment target (188% higher). The listed sponsor is Avenue Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03290378 reports 5 study locations spanning 3 distinct geographic areas - top geographies include California, Texas, Maryland.

Frequently Asked Questions

What is clinical trial NCT03290378 about?

NCT03290378 is a clinical study titled "Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy". The study evaluates the effectiveness and safety of IV tramadol compared to placebo managing postoperative pain following a bunionectomy

What is the current status of trial NCT03290378?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 409 participants. The study started on 2017-09-19. Estimated completion is 2018-04-23.

What conditions does trial NCT03290378 study?

This clinical trial studies the following conditions: Pain Management.

What interventions are being tested in trial NCT03290378?

The interventions under investigation include: Placebo (OTHER), Tramadol (DRUG).

Who is sponsoring clinical trial NCT03290378?

This trial is sponsored by Avenue Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03290378 being conducted?

This trial has 5 study locations across California, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain Management

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.